Elkfork Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$4K Hold
280
﹤0.01% 1052
2019
Q2
$7K Hold
280
﹤0.01% 1046
2019
Q1
$6K Buy
+280
New +$6K ﹤0.01% 1032